XAPLANTERIS, P., S. FOURNIER, N.H.J. PIJLS, W.F. FEARON, E. BARBATO, P.A.L. TONINO, T. ENGSTROM, S. KAAB, J.H. DAMBRINK, G. RIOUFOL, G.G. TOTH, Z. PIROTH, N. WITT, O. FROBERT, Petr KALA, A. LINKE, N. JAGIC, M. MATES, K. MAVROMATIS, H. SAMADY, A. IRIMPEN, K. OLDROYD, G. CAMPO, M. ROTHENBUHLER, P. JUNI and B. DE BRUYNE. Five-Year Outcomes with PCI Guided by Fractional Flow Reserve. New England Journal of Medicine. Waltham: Massachussetts Medical Society, 2018, vol. 379, No 3, p. 250-259. ISSN 0028-4793. Available from: https://dx.doi.org/10.1056/NEJMoa1803538.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Five-Year Outcomes with PCI Guided by Fractional Flow Reserve
Authors XAPLANTERIS, P. (56 Belgium), S. FOURNIER (56 Belgium), N.H.J. PIJLS (528 Netherlands), W.F. FEARON (840 United States of America), E. BARBATO (56 Belgium), P.A.L. TONINO (528 Netherlands), T. ENGSTROM (208 Denmark), S. KAAB (276 Germany), J.H. DAMBRINK (528 Netherlands), G. RIOUFOL (250 France), G.G. TOTH (56 Belgium), Z. PIROTH (348 Hungary), N. WITT (752 Sweden), O. FROBERT (752 Sweden), Petr KALA (203 Czech Republic, belonging to the institution), A. LINKE (276 Germany), N. JAGIC (688 Serbia), M. MATES (203 Czech Republic), K. MAVROMATIS (840 United States of America), H. SAMADY (840 United States of America), A. IRIMPEN (840 United States of America), K. OLDROYD (826 United Kingdom of Great Britain and Northern Ireland), G. CAMPO (380 Italy), M. ROTHENBUHLER (756 Switzerland), P. JUNI (124 Canada) and B. DE BRUYNE (56 Belgium, guarantor).
Edition New England Journal of Medicine, Waltham, Massachussetts Medical Society, 2018, 0028-4793.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30201 Cardiac and Cardiovascular systems
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 70.670
RIV identification code RIV/00216224:14110/18:00104904
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1056/NEJMoa1803538
UT WoS 000439063900008
Keywords in English fractional flow reserve
Tags 14110211, rivok
Tags International impact, Reviewed
Changed by Changed by: Soňa Böhmová, učo 232884. Changed: 10/2/2019 13:03.
Abstract
BACKGROUND We hypothesized that fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) would be superior to medical therapy as initial treatment in patients with stable coronary artery disease. METHODS Among 1220 patients with angiographically significant stenoses, those in whom at least one stenosis was hemodynamically significant (FFR, <= 0.80) were randomly assigned to FFR-guided PCI plus medical therapy or to medical therapy alone. Patients in whom all stenoses had an FFR of more than 0.80 received medical therapy and were entered into a registry. The primary end point was a composite of death, myocardial infarction, or urgent revascularization. RESULTS A total of 888 patients underwent randomization (447 patients in the PCI group and 441 in the medical-therapy group). At 5 years, the rate of the primary end point was lower in the PCI group than in the medical-therapy group (13.9% vs. 27.0%; hazard ratio, 0.46; 95% confidence interval (CIS, 0.34 to 0.63; P<0.001). The difference was driven by urgent revascularizations, which occurred in 6.3% of the patients in the PCI group as compared with 21.1% of those in the medical-therapy group (hazard ratio, 0.27; 95% CI, 0.18 to 0.41). There were no significant differences between the PCI group and the medical-therapy group in the rates of death (5.1% and 5.2%, respectively; hazard ratio, 0.98; 95% CI, 0.55 to 1.75) or myocardial infarction (8.1% and 12.0%; hazard ratio, 0.66; 95% CI, 0.43 to 1.00). There was no significant difference in the rate of the primary end point between the PCI group and the registry cohort (13.9% and 15.7%, respectively; hazard ratio, 0.88; 95% CI, 0.55 to 1.39). Relief from angina was more pronounced after PCI than after medical therapy. CONCLUSIONS In patients with stable coronary artery disease, an initial FFR-guided PCI strategy was associated with a significantly lower rate of the primary composite end point of death, myocardial infarction, or urgent revascularization at 5 years than medical therapy alone. Patients without hemodynamically significant stenoses had a favorable long-term outcome with medical therapy alone.
PrintDisplayed: 7/9/2024 06:16